AscendiantLogo Better
Search
Close this search box.
Contact

Ascendiant Capital Markets

Equity Research

Research Reports

View current research reports or reports on companies.

What We Do

Equity Research

Ascendiant’s Equity Research team provides in-depth research, analysis, and reporting to the investment community.

Ascendiant’s industry focus includes companies in the following sectors: healthcare (biotech, life sciences, medical device), technology, energy, consumer, media and entertainment, and internet.

Ascendiant’s analysts have been awarded top ranking by Starmine and have received multiple StarMine, Wall Street Journal, Forbes, and Institutional Investor analyst awards.

Our analysts have appeared on major media broadcasts such as CNBC, Bloomberg TV, and Fox Business News, and have been quoted in numerous publications such as the Wall Street Journal, the New York Times, and the Los Angeles Times.

Ascendiant’s equity research is distributed to the financial industry’s primary electronic services, portals, and terminals including Bloomberg, Thomson Reuters, S&P Capital IQ, and FactSet, and to Ascendiant’s proprietary investor database.

Contact Us
1516161689013

Edward M. Woo, CFA

Contact Me

View bio
Our Latest Research Reports
  • Sector: Technology

WISA Q2 2023

Nasdaq: WISA

Ascendiant Research Report

  • Sector: Healthcare

ACON Coverage Initiation

Nasdaq: ACON

Ascendiant Research Report

  • Sector: Healthcare

ACON Q2 FY24

Nasdaq: ACON

Ascendiant Research Report

  • Sector: Healthcare

AIM Q4 2021

NYSE American: AIM

Ascendiant Research Report

  • Sector: Healthcare

AIM Q1 2022

NYSE American: AIM

Ascendiant Research Report

  • Sector: Healthcare

AIM Q2 2022

NYSE American: AIM

Ascendiant Research Report

  • Sector: Healthcare

AIM Q3 2022

NYSE American: AIM

Ascendiant Research Report

  • Sector: Healthcare

AIM Q4 2022

NYSE American: AIM

Ascendiant Research Report

  • Sector: Healthcare

AIM Q1 2023

NYSE American: AIM

Ascendiant Research Report

  • Sector: Healthcare

AIM Q4 2023

NYSE American: AIM

Ascendiant Research Report

  • Sector: Healthcare

AIM Q2 2024

NYSE American: AIM

Ascendiant Research Report

  • Sector: Healthcare

ALZN Q3 FY22

Nasdaq: ALZN

Ascendiant Research Report

  • Sector: Healthcare

ALZN Q1 FY23

Nasdaq: ALZN

Ascendiant Research Report

Get To Know Us

Meet the team that makes everything happen. Putting our clients first, and making sure they are successful, is what drives us each and every day. 

Meet The Team
Bradley Wilhite

Bradley J. Wilhite

Co-Founder & Managing Partner

Leadership, Investment Banking

View bio
ASCENDiant Mark

Mark A. Bergendahl

Co-Founder & Managing Partner

Leadership
View bio
Our Values

Our Values

01/08

Relationships

We’re in the money business, but we’re really in the people business. Investing in long-term relationships with clients is a fundamental principle of our business strategy, and one of the most rewarding and enjoyable aspects of what we do.

Our Values

02/08

Trust

Trust, along with excellent communication, is essential in any relationship. We value honesty, integrity, transparency, and reliability, and pledge to always do our best to earn your trust.

Our Values

03/08

Highest Standards

We’re not here to sell you, we’re here to serve you. That means doing what is best for your company and your shareholders – based on your needs and objectives, not ours. We’ve run businesses, too, and now we run an investment bank – that will always put you first.

Our Values

04/08

Serve Clients

Our goal is not to be the biggest bank, it’s to be the best – for the clients we serve. Your best financial partner, your best advisor, your best strategist, your best resource, your best sounding board. The best an investment bank has to offer.

Our Values

05/08

Success

Here’s our simple business philosophy and formula for success – maximize relationships, not fees. Success for us is a client achieving its goals and realizing its potential. When our capital is structured in a way that truly meets your needs – and allows you to hire more employees, open a new building, expand R&D, sell more product, or secure a strategic acquisition, that’s our measure of success.

Our Values

06/08

Experience

Most investors and bankers you meet have never run a business, and even fewer have managed a public company. We have unique perspective and insight from your side of the desk because we’ve been there. We appreciate what you do – tackling challenges and pursuing opportunities – and want to do our best to support you. Let our experience and expertise help you make the best decisions for your company.

Our Values

07/08

Freedom

A public company needs support from a lot of sources to achieve success. That means multiple investors, analysts, shareholders, and yes, investment banks. In short, you need a lot of investment bank friends, not just one. When an investment bank requires exclusivity or a right of first refusal following a capital raise, they are leveraging the relationship and limiting your company’s options. When you work with us, you have freedom, and that’s best for your business.

Our Values

08/08

Respect

Some investment banks are run like a money printing machine – deal after deal, and fees on top of fees. You get calls, e-mails, and texts all hours of the day, night, and weekends, pushing you to accept an offer. That’s not our style, and we’re respectful of your time and your life away from the office. We’ll listen to your needs and objectives, present ideas and solutions, and let you make the call.

Ascendiant News

October 28, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $21,340,000 At-the-Market (ATM) Offering for Giftify, Inc. (Nasdaq: GIFT)
October 10, 2024
Ascendiant Initiates Equity Research Coverage on GRI Bio, Inc. (Nasdaq: GRI)
October 7, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $6,500,000 At-the-Market (ATM) Offering for Alzamend Neuro, Inc. (Nasdaq: ALZN)
September 30, 2024
Ascendiant Capital Markets LLC announced today the filing of a $1,075,000 At-the-Market (ATM) Offering for Aclarion, Inc. (Nasdaq: ACON) of Broomfield, Colorado
September 16, 2024
Ascendiant Capital Markets LLC Serves as Sole Sales Agent on $2,600,000 At-the-Market (ATM) Offering for Auddia Inc. (Nasdaq: AUUD)
September 12, 2024
Ascendiant Serves as Financial Advisor on $2,510,000 Private Placement for Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS)
September 9, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for Allarity Therapeutics, Inc. (Nasdaq: ALLR) Increased to $50,000,000
September 3, 2024
Ascendiant Completes 23rd Year in Business, Moves Forward Into Year 24
August 26, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $3,150,000 Private Placement for Allarity Therapeutics, Inc. (Nasdaq: ALLR)
August 19, 2024
Ascendiant Capital Markets LLC Serves as Sole Placement Agent on $8,250,000 Private Placement for Quantum Computing Inc. (Nasdaq: QUBT)
August 12, 2024
Ascendiant Capital Markets LLC’s At-the-Market (ATM) Offering for The Singing Machine Company, Inc. (Nasdaq: MICS) Increased to $3,100,000
August 5, 2024
Ascendiant Initiates Equity Research Coverage on MIRA Pharmaceuticals, Inc. (Nasdaq: MIRA)

Big enough to deliver

but small enough to care

get in touch
Ascendiant LogoWhite

Services

Resources

Quicklinks

Contact

  • Ascendiant Capital Markets, LLC
Linkedin-in

Important Legal Information & Disclosures

©2024 Ascendiant Capital Markets, LLC, All Rights Reserved.

Member FINRA & SIPC.

a man wearing a suit and tie

Hi there!

How can we help?